白云山(00874)分公司白云山制药总厂获得药品补充申请批件

Core Viewpoint - Recently, Baiyunshan Pharmaceutical Group Co., Ltd. received the "Drug Supplement Application Approval Notice" from the National Medical Products Administration, enhancing the safety information of several drugs and improving market competitiveness [1] Group 1 - Baiyunshan Pharmaceutical's total factory received approval for the following drugs: Abdominal Ankang Tablets, Kunling Pills, Shenxi Dan, Yiganling Tablets, and Mai'an Granules [1] - The approval aims to improve the safety, effectiveness, and rational use of the mentioned drugs [1] - The approval is not expected to have a significant impact on the company's current performance [1]